| Date | Product | Disease | Phase | Company | Therapeutic area |
|---|---|---|---|---|---|
| 2016-05-18 | Lynparza™ (olaparib) | advanced gastric cancer | 3 | AstraZeneca (UK) | Cancer - Oncology |
| 2016-05-18 | oral insulin ORMD-0801 | type 2 diabetes | 2b | Oramed Pharmaceuticals (Israel) | Metabolic diseases |
| 2016-05-17 | BI 695502 (biosimilar version of bevacizumab - Avastin®) | colorectal cancer | 3 | Boehringer Ingelheim (Germany) | Cancer - Oncology |
| 2016-05-17 | MM-121 | ER/PR+, HER2 negative breast cancer | 2 | Merrimack Pharmaceuticals (USA - MA) | Cancer - Oncology |
| 2016-05-16 | CRS-207 and GVAX Pancreas | pancreatic cancer | 2b | Aduro Biotech (USA - CA) | Cancer - Oncology - Rare diseases |
| 2016-05-16 | TOP1630 | dry eye disease | preclinical | Topivert Pharma (UK) | Ophtalmological diseases |
| 2016-05-16 | ProstAtak® (aglatimagene besadenovec) | prostate cancer | 2-3 | Advantagene (USA - MA) | Cancer - Oncology |
| 2016-05-12 | ADU-S100 (also known as MIW815) | solid tumors, lymphoma | Aduro Biotech (USA - CA) Novartis (Switzerland) | Cancer - Oncology | |
| 2016-05-11 | BI 655064 | lupus nephritis | 2 | Boehringer Ingelheim (Germany) | Autoimmune diseases – Inflammatory diseases |
| 2016-05-10 | Lynparza™ (olaparib) and CRLX101 - poly-CD-PEG-camptothecin | advanced solid tumors | 1-2 | Cerulean Pharma (USA - MA) AstraZeneca (UK) National Cancer Institute (NCI) (USA) | Cancer - Oncology |
| 2016-05-10 | reCAP - recombinant human alkaline phosphatase | acute kidney injury | 1 | AM-Pharma (The Netherlands) | Inflammatory diseases - Kidney diseases - Renal diseases |
| 2016-05-10 | PF-06671008 | advanced solid tumors | 1 | Pfizer (USA - NY) | Cancer - Oncology |
| 2016-05-09 | algenpantucel-L | patients with resected pancreatic cancer | 3 | NewLink Genetics (USA - IO) | Cancer - Oncology |
| 2016-05-09 | Pollinex Quattro Birch | birch pollen induced seasonal allergic rhinitis | 2 | Allergy Therapeutics (UK) | Allergic diseases - Inflammatory diseases - Respiratory diseases |
| 2016-05-09 | PRX003 | psoriasis | 1 | Prothena (Ireland) | Autoimmune diseases - Dermatological diseases |
| 2016-05-09 | ND0612 | Parkinson's disease | Neuroderm (Israel) | Neurodegenerative diseases | |
| 2016-05-09 | PF708 (biosimilar teriparatide) | osteoporosis | 1 | Pfenex (USA - CA) | Bone diseases |
| 2016-05-09 | TOP1288 | ulcerative colitis | 1 | Topivert Pharma (UK) | Autoimmune diseases - Inflammatory diseases - Digestive diseases |
| 2016-05-09 | BOW015 - Infimab® (infliximab - biosimilar version of Remicade®) | rheumatoid arthritis | 3 | Epirus Biopharmaceuticals (USA - MA) | Autoimmune diseases – Inflammatory diseases - Rheumatic diseases |
| 2016-05-09 | GLPG2451 | cystic fibrosis | 1 | Galapagos (Belgium) | Rare diseases - Genetic diseases |
